The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma. (July 2017)
- Record Type:
- Journal Article
- Title:
- The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma. (July 2017)
- Main Title:
- The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma
- Authors:
- Brayer, Jason
Baz, Rachid - Abstract:
- The therapeutic armamentarium for multiple myeloma has recently benefited from the addition of several new agents (including second-generation proteasome inhibitors, monoclonal antibodies and histone deacetylase inhibitors). This review will focus on ixazomib, an orally bioavailable second-generation proteasome inhibitor. Specifically, we will review the preclinical data, clinical trial experience, potential indications as well as unanswered questions pertaining to this new agent in multiple myeloma.
- Is Part Of:
- Therapeutic advances in hematology. Volume 8:Number 7(2017)
- Journal:
- Therapeutic advances in hematology
- Issue:
- Volume 8:Number 7(2017)
- Issue Display:
- Volume 8, Issue 7 (2017)
- Year:
- 2017
- Volume:
- 8
- Issue:
- 7
- Issue Sort Value:
- 2017-0008-0007-0000
- Page Start:
- 209
- Page End:
- 220
- Publication Date:
- 2017-07
- Subjects:
- multiple myeloma -- ixazomib -- proteasome inhibitor
Hematology -- Periodicals
Hematologic Diseases -- therapy -- Periodicals
Hematology -- Periodicals
616.15005 - Journal URLs:
- http://tah.sagepub.com/ ↗
http://www.uk.sagepub.com ↗ - DOI:
- 10.1177/2040620717710171 ↗
- Languages:
- English
- ISSNs:
- 2040-6207
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7575.xml